US BioTec (OTCPK:USBC) - Stock Price, News & Analysis

USBC Stock Overview

Engages in the development, manufacture, marketing, and distribution of bio-degradable, nontoxic, and noncarcinogenic products in the United States. More details

USBC fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($41)

Latest financial reports are more than a year old

Shares are highly illiquid

US BioTec, Inc. Competitors

DermTech

OTCPK:DMTK.Q

US$35.0

ObsEva

OTCPK:OBSE.F

US$11.7k

eFFECTOR Therapeutics

OTCPK:EFTR

US$940.0

PLx Pharma Winddown

OTCPK:PLXP.Q

US$30.0

Price History & Performance

Summary of all time highs, changes and price drops for US BioTec
Historical stock prices
Current Share Price	US$0.0001
52 Week High	US$0.0001
52 Week Low	US$0.0001
Beta	0
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	-99.00%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	USBC	US Biotechs	US Market
7D	0%	2.5%	1.0%
1Y	n/a	15.6%	31.4%

Return vs Industry: Insufficient data to determine how USBC performed against the US Biotechs industry.

Return vs Market: Insufficient data to determine how USBC performed against the US Market.

Price Volatility

Is USBC's price volatile compared to industry and market?
USBC volatility
USBC Average Weekly Movement	n/a
Biotechs Industry Average Movement	9.9%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.1%

Stable Share Price: USBC's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine USBC's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Jimmy Joyner	n/a

US BioTec, Inc. engages in the development, manufacture, marketing, and distribution of bio-degradable, nontoxic, and noncarcinogenic products in the United States. Its product portfolio consists of approximately 30 products, which stimulate plants that produce crops; correct microbial and mineral problems present in soils; and rehabilitate the soil ecosystem by breaking down the residual build-up of toxic insecticides, herbicides, fungicides, and synthetic fertilizers. The company provides its products for agriculture, commercial turf industry, forestry, golf courses, professional landscapers, nurseries and mass market retail lawn, and garden markets.

US BioTec, Inc. Fundamentals Summary

How do US BioTec's earnings and revenue compare to its market cap?
USBC fundamental statistics
Market cap	US$41.00
Earnings (TTM)	-US$376.31k
Revenue (TTM)	US$1.64m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is USBC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
USBC income statement (TTM)
Revenue	US$1.64m
Cost of Revenue	US$1.33m
Gross Profit	US$300.98k
Other Expenses	US$677.29k
Earnings	-US$376.31k

Last Reported Earnings

Dec 31, 2005

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did USBC perform over the long term?

See historical performance and comparison